Source comparison
BPC-157 vs Cortisone Injections Heals Better: Clinical and Preclinical Evidence
Pain Reduction (Week 1) Moderate. Inflammation modulation without immunosuppression High. Glucocorticoid-mediated cytokine suppression produces rapid symptom relief Cortisone wins short-term symptom control; BPC-157 acts slower but without repair inhibition St
This comparison does not assign a generated winner or score.
- Pain Reduction (Week 1)
- Moderate. Inflammation modulation without immunosuppression
- High. Glucocorticoid-mediated cytokine suppression produces rapid symptom relief
- Cortisone wins short-term symptom control; BPC-157 acts slower but without repair inhibition
- Structural Repair (MRI at 12 Weeks)
- 40–60% faster tendon-to-bone healing in rat models; increased collagen density and fiber alignment
- No measurable improvement in tendon structure; some studies show collagen density reduction
- BPC-157 shows objective tissue repair; cortisone shows none
- Re-Injury Rate
- No long-term human data available; animal models suggest lower recurrence due to structural repair
- 2.3× higher re-injury rate in athletes vs conservative management (BJSM, 2022)
- Cortisone's symptom suppression masks ongoing structural weakness
- Angiogenesis Markers
- 58% greater capillary density at day 14 (VEGF-mediated); NO pathway activation improves perfusion
- Glucocorticoids suppress VEGF expression. Active inhibition of new vessel formation
- BPC-157 promotes vascularisation; cortisone inhibits it
- Regulatory Status
- Not FDA-approved for human use; available as research peptide only
- FDA-approved for inflammatory conditions; widely used off-label in orthopedics
- Cortisone has regulatory approval; BPC-157 does not
- Cost (Research Context)
- $80–$150 per 5mg vial (research-grade peptide from licensed suppliers like Real Peptides)
- $100–$300 per injection (clinical setting, insurance-dependent)
- Similar cost range; BPC-157 requires self-administration knowledge
- BPC-157 vs cortisone injections heals better when 'healing' is defined as structural tissue repair rather than symptom suppression. The peptide demonstrates measurable effects on collagen synthesis, angiogenesis, and tensile strength recovery in preclinical models. Outcomes cortisone does not produce and, in some cases, actively inhibits.